Third Harmonic Bio, Inc.
THRD
$3.64
$0.174.90%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.92% | 5.86% | 7.23% | 16.65% | 50.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.94% | 12.18% | 3.95% | 3.21% | 16.56% |
| Operating Income | -33.94% | -12.18% | -3.95% | -3.21% | -16.56% |
| Income Before Tax | -47.51% | -10.49% | 9.90% | 18.82% | 12.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.51% | -10.49% | 9.90% | 18.82% | 12.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.51% | -10.49% | 9.90% | 18.82% | 12.32% |
| EBIT | -33.94% | -12.18% | -3.95% | -3.21% | -16.56% |
| EBITDA | -33.94% | -12.13% | -28.48% | -69.23% | -224.13% |
| EPS Basic | -40.88% | -8.58% | 48.99% | 76.49% | 83.80% |
| Normalized Basic EPS | -40.89% | -8.57% | 49.00% | 76.49% | 83.80% |
| EPS Diluted | -40.88% | -8.58% | 48.99% | 76.49% | 83.80% |
| Normalized Diluted EPS | -40.89% | -8.57% | 49.00% | 76.49% | 83.80% |
| Average Basic Shares Outstanding | 4.26% | 1.33% | 24.17% | 69.97% | 177.83% |
| Average Diluted Shares Outstanding | 4.26% | 1.33% | 24.17% | 69.97% | 177.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
